Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Abraham

Showing results (741-750 of 932) with videos related to

Pageof 94
Sort By:
Circulation|February 15, 2001
Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortalityR Dash, V Kadambi, A G Schmidt, et al.
Seminars in Thoracic and Cardiovascular Surgery|January 4, 2017
Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection FractionFred A Weaver, William T Abraham, William C Little, et al.
European Journal of Heart Failure|November 14, 2008
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)Joseph S Rossi, James D Flaherty, Gregg C Fonarow, et al.
European Journal of Heart Failure|April 9, 2025
Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus documentBiykem Bozkurt, Wilfried Mullens, Christophe Leclercq, et al.
International Journal of Cardiology|April 30, 2018
Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery diseaseMarcel Halbach, William T Abraham, Christian Butter, et al.
Journal of the American College of Cardiology|February 7, 2024
Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection FractionJoAnn Lindenfeld, Maria Rosa Costanzo, Michael R Zile, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 9, 2025
Clinical phenotypes and outcomes associated with improved left ventricular ejection fraction after biventricular pacingSameer A Kunte, Lurdes Y T Inoue, William T Abraham, et al.
American Heart Journal|May 26, 2009
Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)James D Flaherty, Joseph S Rossi, Gregg C Fonarow, et al.
Circulation. Heart Failure|October 12, 2017
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial FibrillationSøren Lund Kristensen, Pardeep S Jhund, Ulrik M Mogensen, et al.
Circulation|September 17, 2008
Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressuresMichael R Zile, Tom D Bennett, Martin St John Sutton, et al.
Pageof 94

Showing results (741-750 of 932) with videos related to

Sort By:
Pageof 94
Circulation|February 15, 2001
Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortalityR Dash, V Kadambi, A G Schmidt, et al.
Seminars in Thoracic and Cardiovascular Surgery|January 4, 2017
Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection FractionFred A Weaver, William T Abraham, William C Little, et al.
European Journal of Heart Failure|November 14, 2008
Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)Joseph S Rossi, James D Flaherty, Gregg C Fonarow, et al.
European Journal of Heart Failure|April 9, 2025
Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus documentBiykem Bozkurt, Wilfried Mullens, Christophe Leclercq, et al.
International Journal of Cardiology|April 30, 2018
Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery diseaseMarcel Halbach, William T Abraham, Christian Butter, et al.
Journal of the American College of Cardiology|February 7, 2024
Implantable Hemodynamic Monitors Improve Survival in Patients With Heart Failure and Reduced Ejection FractionJoAnn Lindenfeld, Maria Rosa Costanzo, Michael R Zile, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|April 9, 2025
Clinical phenotypes and outcomes associated with improved left ventricular ejection fraction after biventricular pacingSameer A Kunte, Lurdes Y T Inoue, William T Abraham, et al.
American Heart Journal|May 26, 2009
Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)James D Flaherty, Joseph S Rossi, Gregg C Fonarow, et al.
Circulation. Heart Failure|October 12, 2017
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide Levels in Heart Failure Patients With and Without Atrial FibrillationSøren Lund Kristensen, Pardeep S Jhund, Ulrik M Mogensen, et al.
Circulation|September 17, 2008
Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressuresMichael R Zile, Tom D Bennett, Martin St John Sutton, et al.
Pageof 94